JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, no par value, Aurinia Pharmaceuticals Inc., a Canadian corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: October 23, 2017
| GENIUS INC. | |||
| By: |
/s/ Xxxx Xxxxx | ||
| Name: | Xxxx Xxxxx | ||
| Title: | Chief Financial Officer | ||
|
/s/ Xxxxxx X. Xxxxxx | |
| Xxxxxx X. Xxxxxx |
